Tecan completes acquisition of Sias

Tecan has announced the completion of its acquisition of Sias, a leading OEM supplier of modular and complete laboratory automation solutions.

The company agreed to purchase the business in October and has now finalised the deal, meaning Sias will now operate as part of its partnering business segment, commencing on December 1st.

It is expected that this acquisition will bring new corporate customers in the in-vitro diagnostics segment and expand Tecan's portfolio of new development projects, with the takeover deal valued at 25 million Swiss francs (16.24 million pounds).

Sias is known for its core expertise in automating immunoassays and molecular diagnostics workflows, as well as its strong client base in China, meaning it aligns naturally with Tecan's strategic focus.

The acquired company has around 80 employees and supplies customers in Europe, the US and China.

Dr David Martyr, chief executive officer of Tecan, said: "Sias will add further scale to our leading partnering business and provides access to complementary automation platforms that are particularly well-suited as the basis for small to mid-size OEM systems for diagnostic as well as research applications."